Occlusion Perfusion Catheter Demonstrates Superior Performance in PAD Drug Delivery
02 nov. 2023 08h28 HE
|
Advanced Catheter Therapies
Researchers successfully demonstrate the delivery of liquid sirolimus into the arterial wall using the OPC, which can also be used for paclitaxel BTK.
Antiplatelet Drugs Market to Hit USD 4.1 Bn by 2031 Due to the Increase in Prevalence of Cardiovascular Diseases, Latest Study by TMR
20 mars 2023 17h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, March 21, 2023 (GLOBE NEWSWIRE) -- According to Transparency Market Research, the global antiplatelet drugs market size was valued USD 2.1 Bn in 2022 and it is...
Amaranth Medical Completes MEND-II and RENASCENT Studies and Initiates Study of 120-Micron APTITUDE Sirolimus-Eluting Bioresorbable Scaffold
15 oct. 2015 08h00 HE
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA, Oct. 15, 2015 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, announced that enrollment has successfully concluded in its multi-center, international...
Amaranth Medical Initiates Clinical Trial of the Second-Generation FORTITUDE Bioresorbable Drug-Eluting Scaffold
16 sept. 2014 09h00 HE
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA, Sept. 16, 2014 (GLOBE NEWSWIRE) -- Amaranth Medical, a
privately held medical device company, announced the initiation of
patient enrollment in multiple centers in Colombia, South...
Amaranth Medical Reports Positive Safety and Feasibility Findings for the FORTITUDE(TM) Bioresorbable Scaffold
28 oct. 2013 08h00 HE
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA, Oct. 28, 2013 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company,
presented positive six-month angiographic results from its
first-in-human study...
Atlanta Catheter Therapies Completes $2.98 Million Series A Equity Financing
29 sept. 2011 11h48 HE
|
Atlanta Catheter Therapies
ATLANTA, GA and CHATTANOOGA, TN--(Marketwire - Sep 29, 2011) - Atlanta Catheter Therapies, Inc. (ACT) has raised a total of $2.98 million in Series A equity financing through an investment...
Atlanta Catheter Therapies Receives Grant Through Qualifying Therapeutic Discovery Project
05 nov. 2010 11h14 HE
|
Atlanta Catheter Therapies
ATLANTA, GA--(Marketwire - November 5, 2010) - Medical device company Atlanta Catheter Therapies, Inc. (ACT) has received a grant for almost $250,000 through the Qualifying Therapeutic Discovery...
High Interest From VC Forums in Atlanta Catheter Therapies
25 oct. 2010 14h49 HE
|
Atlanta Catheter Therapies
ATLANTA, GA--(Marketwire - October 25, 2010) - Medical device company Atlanta Catheter Therapies, Inc. (ACT) is generating high interest in its innovative intravascular catheterization which...
Atlanta Catheter Therapies Selected for Investor Conferences
19 avr. 2010 08h13 HE
|
Atlanta Catheter Therapies
ATLANTA, GA and BOSTON, MA--(Marketwire - April 19, 2010) - Atlanta Catheter Therapies, Inc. (ACT) has been selected to present at the Biotech & Healthcare Venture Summit 2010, presented by...
Innovative Vascular Catheterization Approach Offers New Hope
24 mars 2010 13h42 HE
|
Atlanta Catheter Therapies
ATLANTA, GA--(Marketwire - March 24, 2010) - Atlanta Catheter Therapies, Inc. (ACT) has successfully completed the prototyping phase for an innovative medical device that integrates drug...